PLx Pharma, Inc.
(NASDAQ : PLXP)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc. 0.82%31.8214.1%$187.23m
SAVACassava Sciences, Inc. 16.05%77.000.0%$173.62m
HZNPHorizon Therapeutics Plc -0.70%93.295.5%$144.00m
JAZZJazz Pharmaceuticals Plc 0.12%186.172.2%$112.10m
CTLTCatalent, Inc. 0.21%109.102.1%$104.08m
ICLRICON plc -0.74%216.184.2%$103.64m
ARGXargenx SE 1.87%314.670.0%$68.57m
UTHRUnited Therapeutics Corp. -0.76%179.1214.0%$66.46m
BHCBausch Health Cos., Inc. 0.82%31.820.0%$65.43m
PRGOPerrigo Co. Plc -2.29%47.756.9%$57.09m
SAGESAGE Therapeutics, Inc. 3.97%79.117.6%$40.11m
PCRXPacira Biosciences, Inc. 2.26%60.529.9%$29.62m
RVMDRevolution Medicines, Inc. 1.93%34.270.0%$23.00m
AXSMAxsome Therapeutics, Inc. -1.75%66.391.9%$22.28m
ICPTIntercept Pharmaceuticals, Inc. 0.28%21.5616.7%$21.57m

Company Profile

PLx Pharma, Inc. is a late-stage specialty pharmaceutical company, which engages in the development and commercialization of technology platform for approved drugs. It offers PLxGuard delivery system, which uses surface acting lipids, such as phospholipids and free fatty acids, to modify the physiochemical properties of various drugs with a targeted release to select portions of the gastrointestinal (GI) tract. The company was founded by Ronald R. Zimmerman on November 12, 2002 and is headquartered in Sparta, NJ.